Form 4 for CRH CRH plc
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000950170-25-033703 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | CRH | Buckley Peter J. | See Remarks | F - Tax | $95.23 | -14.2K | 155.6K | -8% | -$1.35M |
| D | 2025-03-05 | 2025-03-03 | CRH | Buckley Peter J. | See Remarks | A - Grant | $0.00 | +27.3K | 169.8K | +19% | $0 |
| D | 2025-03-05 | 2025-03-03 | CRH | Buckley Peter J. | See Remarks | A - Grant | — | +3,877 | 3,877 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-03 | F | D | 14,158 | $95.23 | 155,606 | D | — | — | (F2) Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in the connection with the aforementioned awards (F3) The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $92.75 and $98.705 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request. |
| 2 | Common | Ordinary Shares | 2025-03-03 | A | A | 27,278 | $0.00 | 169,764 | D | — | — | (F1) Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 2,284 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee"). |
| 3 | Derivative | Deferred Share Award | 2025-03-03 | A | A | 3,877 | — | 3,877 | D | $0.00 · — to — | 3,877 Ordinary Shares | (F4) Reflects time-based conditional awards, as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, subject to the determination of the Compensation Committee, the balance will vest in March 2028. In accordance with the DSB Plan Rules, dividend equivalents will apply to the Award and, to the extent awarded, will be reported at the time of vesting. |